Deerfield Private Design Fund II, L.P.
CIK 1483687 · last filed 2018-06-25
Deerfield Private Design Fund II, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing shows the insider sold $4.8M of AVDL on Jun 25, 2018. Across all open-market trades the lifetime net is +$1.5M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
2
$1.46M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | 952,265 | $21.64 | $20.61M | -$4.78M | 1 | 2018-06-25 | |
| ALIMERA SCIENCES INC (ALIM) Delisted | 10%+ Owner | 274,102 | $5.54 | $1.52M | $6.24M | 1 | 2015-10-09 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-25 | AVADEL PHARMACEUTICALS PLC (AVDL) Delisted | Sell (S) | −798,238 | -$4.78M | EDGAR |
| 2015-10-09 | ALIMERA SCIENCES INC (ALIM) Delisted | Buy (P) | +2,574,280 | $6.24M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.